Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

University of British Columbia

$612,000.00

Functional Studies of Coding Variants in Polycomb Repressive Complex Found in Humans

EF 2019-20

Résumé
DNA sequencing has ushered in a "Golden Age" of disease discovery. The causes of many rare genetic diseases have been found, and the genetic contributions to common diseases are also being solved very quickly. However, digging through multiple human genomes has unearthed thousands of new DNA variants, and often it isn't obvious which ones are the disease-causing mutations that affect health, and which other ones have no health effects. Our lab focuses on rare mutations that cause human overgrowth. Overgrowth syndromes cause tall stature, large head size and medical problems such as obesity, cancer, autism and intellectual disability. Having discovered the overgrowth syndromes that are caused by rare mutations in the "PRC2" group of proteins, we're now trying to understand exactly which DNA variants in PRC2 cause overgrowth and which ones don't. We have also found that some PRC2 mutations cause other medical problems, such as muscle fatigue and even stunted growth (i.e. the opposite of overgrowth). In this project we seek to recruit people who have rare DNA variants in PRC2 members, so we can follow them over time and find out what medical problems they have (if any). Because the human PRC2 genes each have an analogous gene that does pretty much the same thing in fruit flies, we plan to engineer our human mutations into experimental fruit flies. In this way we can figure out which of our variants are true mutations that produce a non-working protein, and which variants produce a protein that works well enough to allow normal function. By taking advantage of the wealth of molecular techniques that exist for fruit flies, we can quickly find out which human variants are likely to be benign with no effects on health, and which human variants are likely to be disease-causing mutations. The data from our study will help diagnostic labs sort out the small number of disease-causing PRC2 variants from the larger number of benign DNA variants in the PRC2 proteins.
Programme
Project Grant
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
409265
Name
Gibson William T
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Genetics
Projecttitle
Functional Studies of Coding Variants in Polycomb Repressive Complex Found in Humans
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$612,000
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Animal Modelling; Drosophila; Epigenetic Modifications; Functional Studies; Overgrowth Syndromes; Prc2-Complex
Abstract
DNA sequencing has ushered in a "Golden Age" of disease discovery. The causes of many rare genetic diseases have been found, and the genetic contributions to common diseases are also being solved very quickly. However, digging through multiple human genomes has unearthed thousands of new DNA variants, and often it isn't obvious which ones are the disease-causing mutations that affect health, and which other ones have no health effects. Our lab focuses on rare mutations that cause human overgrowth. Overgrowth syndromes cause tall stature, large head size and medical problems such as obesity, cancer, autism and intellectual disability. Having discovered the overgrowth syndromes that are caused by rare mutations in the "PRC2" group of proteins, we're now trying to understand exactly which DNA variants in PRC2 cause overgrowth and which ones don't. We have also found that some PRC2 mutations cause other medical problems, such as muscle fatigue and even stunted growth (i.e. the opposite of overgrowth). In this project we seek to recruit people who have rare DNA variants in PRC2 members, so we can follow them over time and find out what medical problems they have (if any). Because the human PRC2 genes each have an analogous gene that does pretty much the same thing in fruit flies, we plan to engineer our human mutations into experimental fruit flies. In this way we can figure out which of our variants are true mutations that produce a non-working protein, and which variants produce a protein that works well enough to allow normal function. By taking advantage of the wealth of molecular techniques that exist for fruit flies, we can quickly find out which human variants are likely to be benign with no effects on health, and which human variants are likely to be disease-causing mutations. The data from our study will help diagnostic labs sort out the small number of disease-causing PRC2 variants from the larger number of benign DNA variants in the PRC2 proteins.
Competitiondate
201909
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Gibson, William T
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $612,000~ $0~